Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Aug 25, 2016; 8(16): 553-557
Published online Aug 25, 2016. doi: 10.4253/wjge.v8.i16.553
Published online Aug 25, 2016. doi: 10.4253/wjge.v8.i16.553
All patients | |
Patients (n) | 320 |
Age (mean years ± SD) | 65.03 ± 16.11 |
BMI (mean years ± SD) | 28.47 ± 9.75 |
Gender | |
Male (n) | 169 |
Female (n) | 151 |
Outcome | No plavix | Plavix | P value |
Patients (n) | 286 | 33 | - |
Age (mean years ± SD) | 64.37 ± 16.44 | 71.21 ± 11.43 | 0.02 |
BMI (mean years ± SD) | 28.30 ± 9.59 | 29.25 ± 10.66 | 0.60 |
Hgb drop < 48 h | 5 | 2 | 0.16 |
Local complications < 48 h | 8 | 2 | 0.28 |
Transfusions < 48 h | 7 | 2 | 0.24 |
Rescope < 48 h | 1 | 1 | 0.20 |
- Citation: Sohail U, Harleen C, Mahdi AO, Arif M, Nguyen DL, Bechtold ML. Bleeding risk with clopidogrel and percutaneous endoscopic gastrostomy. World J Gastrointest Endosc 2016; 8(16): 553-557
- URL: https://www.wjgnet.com/1948-5190/full/v8/i16/553.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i16.553